111759-97-8

Basic information

• Product Name: Piperazine, 2-(2-pyridinyl)-
• Synonyms: 2-PYRIDIN-2-YL-PIPERAZINE;Piperazine, 2-(2-pyridinyl)-;2-(PYRIDIN-2-YL)PIPERAZINE 2HCL
• CAS NO: 111759-97-8
• Molecular Formula: C₉H₁₃N₃
• Molecular Weight: 163.22
• Mol File: 111759-97-8.mol

Chemical Properties

• Boiling Point: 316.6±32.0 °C(Predicted)
• Appearance: /
• Density: 1.046±0.06 g/cm3(Predicted)
• PKA: 8.31±0.40(Predicted)
• CAS DataBase Reference: Piperazine, 2-(2-pyridinyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Piperazine, 2-(2-pyridinyl)-(111759-97-8)
• EPA Substance Registry System: Piperazine, 2-(2-pyridinyl)-(111759-97-8)

Safety Data

• Hazardous Substances Data: 111759-97-8(Hazardous Substances Data)

Upstream product

• 109-04-6 2-bromo-pyridine 
• 14508-49-7 2-chloropyrazin 

Downstream Products

• 1258411-09-4 C₂₄H₂₄ClN₉OS 

Relevant articles and documents

ANTAGONISTS OF GPR39 PROTEIN

Novel compounds that act as antagonists to human GPR39 protein are disclosed. Pharmaceutical compositions and methods of use for antagonists to human GPR39 protein are disclosed. In particular, methods of using the antagonists in the treatment of diseases or conditions including cardiovascular conditions, endocrine system and hormone disorders, cancer disorders, metabolic diseases, gastrointestinal and liver diseases, hematological disorders, neurological disorders and respiratory diseases are disclosed herein.

Transition metal complex, polymer, mixture, composition and organic electronic device

The invention discloses a transition metal complex. The complex is represented by general formula (1) shown in the specification, G in the specification is selected from cycloalkane or a cage group, and the cage group is coordinated with a metal center in a monovalent anion form to obtain a more stable complex structure. The transition metal complex provided by the invention is used in an OLED, especially as a luminescent layer doping material, not only can provide higher luminous efficiency and longer device life, but also can improve the brightness and current efficiency of the device, and meanwhile, reduces the starting voltage to prolong the service life of the device.

7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids

7-(substituted)piperazinyl-1-ethyl-6-fluoro-4-oxo-3-quinolinecarboxylic acids, the pharmacologically acceptable salts thereof, compositions containing them, processes and intermediates for producing them, and methods of using them to treat bacterial infections in warm-blooded animals.